Quilter Plc’s BioMarin Pharmaceuticals BMRN Stock Holding History

Quilter Plc’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,868	Closed	-$230K	–	296
2020 Q2	$230K	Buy	+1,868	New	+$186K	0.01%	214

Other funds holding BMRN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Quilter Plc's BMRN Position: Q3 2020 in Review

Quilter Plc sold out of BioMarin Pharmaceuticals (BMRN) in Q3 2020, closing a stake of 1,868 shares — an estimated $230K sold.

Quilter Plc first reported a position in BMRN in Q2 2020 and held it in 1 quarter. The position peaked at $230K in Q2 2020. 496 funds tracked by Wall St. Rank hold BMRN as of Q3 2020.

Quilter Plc reported no remaining BioMarin Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
Quilter Plc sold 1,868 BioMarin Pharmaceuticals shares in Q3 2020, an estimated $230K.
Quilter Plc first reported a position in BioMarin Pharmaceuticals in Q2 2020 and held it in 1 quarter.
Quilter Plc's BioMarin Pharmaceuticals position peaked at $230K in Q2 2020.
496 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2020.

Based on Quilter Plc's 13F filing for Q3 2020, filed 12 Nov 2020.